Archive: November 2025
Feature
Primary Biliary Cholangitis: Novel and Emerging Therapies
Abstract: Primary biliary cholangitis (PBC) is a slowly progressive autoimmune liver disease that, if not promptly and appropriately treated, can lead to significant morbidity, mortality, and […]
Feature
Understanding Inflammatory Bowel Disease in Women From Puberty to Menopause
Abstract: Women with inflammatory bowel disease (IBD) experience distinct physiologic and clinical challenges across their lifespan. In childhood and adolescence, early exposure to corticosteroids, chronic inflammation, […]
Advances in IBS
Health Disparities in Irritable Bowel Syndrome
G&H What did the National GI Survey II reveal about the prevalence and burden of irritable bowel syndrome in the United States? CA The findings of […]
Advances in IBD
Anastomoses for Ileocolonic Resection in Patients With Crohn’s Disease
G&H What are the most common types of anastomoses currently being used for ileocolonic resection in Crohn’s disease? FM There are currently 4 types of anastomoses. […]
Advances in Hepatology
Diagnosis and Management of Portal Vein Thrombosis in Patients With Cirrhosis
G&H Is there any need for portal vein thrombosis screening in patients with compensated cirrhosis who do not have any symptoms? JL This is a very […]
Letter From the Editor
Letter From the Editor: Exploring Current and Emerging Therapies for Patients With Primary Biliary Cholangitis
Up to 40% of patients with primary biliary cholangitis (PBC) do not respond adequately to ursodeoxycholic acid, which is well established for first-line treatment. One of […]